Gdsl lipase, genetically-engineered bacteria and application thereof
Abstract
The invention relates to a GDSL lipase, genetically-engineered bacteria and an application thereof. The GDSL lipase is derived from Streptomyces diastaticus CS1801 and its amino acid sequence is as shown in SEQ ID NO.2. After construction of a genetically-engineered bacterium strain, a GDSL lipase is generated through fermentation. Through this enzyme, vitamin A and palmitic acid are converted to produce vitamin A palmitate. The content of the vitamin A palmitate obtained from the conversion is 16.35 mg/L at most. The conversion efficiency is 81.75% at most. This lipase provides a new path to synthesize vitamin A palmitate by the enzymatic method and has an important application prospect.
Claims
exact text as granted — not AI-modified1 . A GDSL lipase, wherein its amino acid sequence is as shown in SEQ ID NO.2.
2 . A gene encoding the GDSL lipase as in claim 1 .
3 . The gene according to claim 2 , wherein its nucleotide sequence is as shown in SEQ ID NO.1
4 . A recombinant vector containing the gene as in claim 3 .
5 . The recombinant vector according to claim 4 , wherein its expression vector is pET 32a(+).
6 . An engineered bacterium containing the recombinant vector as in claim 5 .
7 . The engineered bacterium according to claim 6 , wherein the host cell is E. coli BL21(DE3).
8 . An application of the engineered bacterium as in claim 6 in the production of vitamin A palmitate, including:
(1) inoculating the engineered bacterium to an LB medium for seed culture;
(2) transferring the seed solution to a fermentation medium for fermentation culture, and then adding an inducer to induce expression of enzymes;
(3) centrifuging the fermentation broth to obtain a supernate, and obtaining enzyme powder through precipitation by ammonium sulfate and lyophilization; and
(4) adding the enzyme powder to an organic phase system containing vitamin A and palmitic acid to produce vitamin A palmitate.
9 . The application according to claim 8 , wherein the fermentation medium comprises:
tryptone 10 g/L, yeast powder 5 g/L, NaCl 10 g/L, MgSO 4 .7H 2 O 1 g/L, KH 2 PO 4 0.5 g/L, K 2 HPO 4 0.5 g/L, olive oil emulsion 12 mL/L, and distilled water added till volume 1 L.
10 . The application according to claim 9 , wherein the olive oil emulsion is prepared by the following method: mixing olive oil emulsifier PVA with olive oil at a volume ratio of 3:1 and emulsifying the mixture by ultrasound.Join the waitlist — get patent alerts
Track US2022033789A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.